Inspire Medical Systems, Inc. (INSP)

NYSE • Healthcare

$71.11

-$1.54 (-2.1%)

Market open

Last close at October 23, 2026 at 20:00 UTC

Open$72.25

Previous Close$71.11

Day Range$68.44 - $72.75

Avg. Volume (3M)866.8K

Market Cap$2B

P/E Ratio15.3

52 Week Range

$38.91$147.03

Next EarningsIn 8 daysNov 2, 2026

Metrics Over Time

Where the Money Goes

Q2 2026

Revenueeverything earned$200.5M100%

Gross Profitminus cost of goods$171.4M85%

Net Incomeminus taxes and the rest$314K0%

Fundamentals & Financials

Revenue (TTM)

$898.7M

Net Income (TTM)

$135M

EPS (TTM)

$4.66

ROA (TTM)

14.58%

Current Ratio

8.55

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings

+104.5%Q3 2025$0.45

+353.3%Q4 2025$0.38

+139.1%Q1 2026$1.65

+136.3%Q2 2026$0.1

+159.3%Q3 2026$0.14

Nov 2

in 8 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026

Beat +159.3%

Inspire Medical Systems beat consensus on both revenue and adjusted EPS in the second fiscal quarter of 2026, based on preliminary results reported August 3, with the operating segment generating about $200.6 million of revenue. Revenue fell about 8% to about $200.6 million from about $217.1 million a year ago, but still topped the $194.7 million estimate by about 3%; adjusted EPS of $0.14 was down about 69% from $0.45 a year ago and topped the -$0.24 estimate by about 159%. Gross profit reached about $171.5 million and gross margin held near 86%, while operating cash flow was about $23.2 million. Next-period consensus calls for EPS of $0.12 on revenue of $203.3 million.

Next report — what to expect

Inspire Medical Systems, Inc. (INSP) reports on November 2, 2026. Wall Street is looking for consensus EPS of $0.10 on consensus revenue of $204.1 million. For trailing context, revenue was down -7.6% year over year last quarter. INSP has beaten EPS in 8 of 8 most recent quarters.

View full earnings history

About Inspire Medical Systems, Inc.

Inspire Medical Systems, Inc. develops and commercializes minimally intrusive therapies for obstructive sleep apnea, operating in healthcare as a maker of medical devices. Listed on the NYSE as INSP, the company generates revenue from its neurostimulation platform, with $912.0 million reported for FY2025.

Name

Inspire Medical Systems, Inc.

CEO

Timothy Herbert

Website

www.inspiresleep.com

Industry

Healthcare

Year Founded

2007

Employees

1,333

Today's Snapshot

AI-generated

The day ended with INSP 2.1% lower at 71.10, in line with a weaker sector. Shares changed hands at about half of its usual level. Inspire Medical Systems reported an earnings beat.

Trading Volume

Below 10d avg (733.4K)

388.4K

vs S&P 500 Today

Underperforming Market

-1.63%

Updated: October 23, 2026 at 20:12 UTC

Technical Indicators

6 Buy2 Neutral0 Sell

INSP at 71.11 reflects a strong buy profile with clear trend support and momentum. Short- and medium-term moving averages are below the price and the 200-day average is likewise supportive, while MACD and momentum readings favor the upside and ADX above 25 signals a meaningful trend. Volatility is moderate per ATR, but on-balance volume is lagging, which tempers conviction somewhat. The classic pivot sits overhead near 72.15, marking a nearby level to monitor. Technical takeaway: Strong buy — momentum and moving averages are aligned, though volume does not yet fully confirm.

All signals